Skip to main content

Practice points for lymphoedema care in low- and middle- income countries developed by nominal group technique

Abstract

Background

Lymphoedema is a common, distressing, and debilitating condition affecting more than 200 million people globally. There is a small body of evidence to guide lymphoedema care which underpins several lymphoedema clinical practice guidelines developed for high-income countries (HIC). Some of these recommendations are unlikely to be feasible in low-resource settings.

Aim

To develop practice points for healthcare workers that optimise lymphoedema care in low- and middle-income countries (LMIC).

Methods

A nominal group technique (NGT) was undertaken to gain consensus on which content from HIC guidelines was important and feasible to include in practice points for LMIC, and other important advice or recommendations. Participants included experts, clinicians, and volunteers involved in lymphoedema care in LMIC. The NGT followed five key stages: silent ‘ideas’ generation, round-robin rationale, clarification, refinement and verification. The first, fourth and fifth stages were completed via email, and the second and third during a video meeting in order to generate a series of consensus based prevention, assessment, diagnosis, and management of lymphoedema in LMIC practice points.

Results

Of sixteen participants invited, ten members completed stage 1 of the NGT (ideas generation), of whom six contributed to stages 2 (round-robin) and 3 (clarification). All those who completed stage 1 also completed stages 4 (refinement) and 5 (verification). Practice points unanimously agreed on included Complex Decongestive Therapy (CDT) and good skin care, with management to be determined by lymphoedema stage. For podoconiosis-endemic areas, the use of socks and shoes was identified as very important in the prevention of non-filarial lymphoedema and other lymphoedema-causing conditions. Participants indicated that diagnosing lymphoedema using the lymphoscintigraphy and Indocyanine green (ICG) fluorescent lymphography was not possible due to unavailability and cost in LMIC. Surgical procedures for lymphoedema management were unanimously eliminated due to the unavailability of technology, limited workforce, and expensive cost in LMIC.

Conclusion

The consensus-based practice points generated by this project provide healthcare workers with guidance on caring for people with lymphoedema in LMIC. Further development of workforce capacity is needed.

Peer Review reports

Background

Lymphoedema is a chronic and debilitating condition, often referred to as the “forgotten complication” because it can be mistaken for oedema, venous insufficiency or heart disease [1,2,3]. Globally, more than 200 million people are affected by lymphoedema [4], the majority of whom live in low- and middle-income countries (LMIC). The condition impacts negatively on quality of life, interferes with activities of daily living and ability to work, and is traumatic for the individuals affected and their families, lymphoedema alters their “sense of identity” and reduces their ability to participate in social events [5, 6].

Compared to people in high-income countries (HIC), those living in LMIC are often diagnosed at a later stage and with more advanced forms of lymphoedema [7]. They also have fewer treatment options, which increases their risk of developing complications and poorer health [8]. Unlike in HIC where cancer treatment is the major cause of lymphoedema, the most common cause of lymphoedema in LMIC is infectious lymphatic filariasis, while others suffer from the “swollen limb syndrome” [9, 10]. The World Health Organisation (WHO) reported that there has been a rapid reduction (74%) in lymphatic filariasis since the beginning of the ‘Global Programme to Eliminate Lymphatic Filariasis’ in 2000, limiting the impact of the disease in most areas [9, 11]. However, lymphoedema from other causes such as cancer, podoconiosis, idiopathy and trauma remains a major problem.

A recent systematic review [12] identified ten lymphoedema guidelines for HIC but only one for LMIC: the WHO Wound and Lymphoedema Management [13], which focuses exclusively on lymphoedema caused by infectious filariasis and wounds, and has very limited content on diagnosis and assessment. Unfortunately, recommendations in HIC guidelines are not always transferable to LMIC, especially when access to specialist services is limited and healthcare workers lack high levels of expertise to provide optimal care [14]. In many LMIC, awareness of lymphoedema by the general public is limited and those affected are often stigmatised due to cultural beliefs [15]. Finally, financial constraints for many people in LMIC negatively affect their capacity to pay for medical supplies and professional support.

In the absence of robust evidence to guide the prevention, identification and management of lymphoedema in LMIC, ‘practice points’ can fill this gap and are often highly valued by health workers. Practice points are sets of recommendations that are developed through expert opinion when evidence is insufficient or outside the scope of systematic reviews [16].

The current research aimed to develop practice points for healthcare workers that optimise lymphoedema care in LMIC.

Methods

Design

A nominal group technique (NGT) using a formal consensus process, was adopted as an interpretative method for generating a series of lymphoedema care practice points [17, 18].

A NGT is a technique of interviewing where group members independently provide ideas without interrupting each other [19]. The technique emphasizes considering all participants' views equally and enhancing group dynamics [18]. The NGT has been used in the past to evaluate priorities for health services, and formulate policies both in treatment of health conditions including cancer and in other health settings [20, 21]. The group deliberation and discussion of specific topics used in NGT help to minimise misunderstanding on a topic and provide highly suitable responses [20]. Where evidence is limited like in the area of lymphoedema care in LMIC, NGT consensus provides a useful method in developing clinical practice points.

Participants and setting

To be eligible to contribute, participant needed to be: a) expert on the diagnosis, assessment and/or management of lymphoedema from any cause, as denoted by authorship on a relevant journal article and/or b) health professional or caregiver in a World Bank Group [22] LMIC in the ‘paid’ or voluntary capacity.

Recruitment strategy

Participants were sampled using two non-probabilistic methods: purposive and snowballing methods [23, 24]. Initial approach was via email invitation to authors of relevant journal articles identified by a systematic review of lymphoedema studies in LMIC [25], personal and professional networks, and through organizations with an interest in lymphoedema care in LMIC, as well as to participants of previous research on lymphoedema care in LMIC [26].

Email invitations to individuals were followed up with a reminder after a week, to ensure that people had ample opportunity to respond without unduly ‘pestering’ them. A non-response to the follow up email was considered a decline to participate [27].

Participants who completed the first stage on the idea generation survey via email were invited to participate in stages 2 to 5.

Data collection

The NGT consensus was used to identify which key topic areas should be prioritised for simple and practical guidance on lymphoedema care for clinicians in LMIC. This work followed an adapted version of McMillan et al. [28] five NGT stages, as summarised below:

Stage 1

Stage 1 (silent generation) is an idea generation stage. Participants were emailed a list of topic areas from the HIC guidelines asking them to individually reflect on which ones they think are most important and feasible for LMIC as well as to add any further ideas they have for such guidance. Each participant returned their ideas to the first investigator (ET) for him to identify areas of agreement and disagreement.

Stage 2

In a ‘round robin’ stage, participants attending a meeting were asked to explain the rationale for their ‘top choice’ for inclusion in the clinician guidance. If a participant’s top choice had already been put forward by someone else, (s)he was invited to choose another. The round robin continued until everyone’s choices were exhausted. No group discussion or commentary by the facilitator occurred at this stage. This stage and stage 3 were completed at a video meeting facilitated by the second author (TL), with notes taken by ET.

Stage 3

The next stage focused on clarification of ideas via group discussion, in which participants were asked to identify areas of overlap or synergy between the selected topics to create themes, ensuring that the list was coherent and not repetitive. At this stage, participants could also agree to exclude or alter ideas, as well as generate new ideas. Feasibility in terms of cost for each recommendation was appraised subjectively by NGT participants based on their own experience rather than using a pre-specified monetary threshold.

Stage 4

In the fourth stage (refinement), the group choices from the list created at Stage 3 for each domain of the guidance document were sent via email to participants for verification. Participants were allowed to comment on the guidance document individually rather than as a group to ensure all participants’ opinions were captured. Where a practice point was suggested by a participant that was additional to those in the HIC guidelines, a Medline database search was conducted to check the evidence available either in support or against the suggestion. Where evidence was considered favourable or absent, the suggestion was put forward for discussion and consensus. Consensus was defined as a 100% agreement from all participants.

Recommendations were graded based on the systems as reported by the International Lymphoedema Framework [29]. Levels of evidence for each recommendation were defined by the relevant guideline(s) from which it was sourced. All of the guidelines except two [30, 31] used the grading system described by the International Lymphoedema Framework [27]:

  • Grade A—clear research evidence obtained from meta-analysis or systematic review of randomized controlled trials;

  • Grade B—limited supporting research evidence; and

  • Grade C—experienced common sense judgement (consensus) [29].

Stage 5

In the final stage (verification), results from the fourth Stage were presented back to the group for discussion and consensus, again via email. Where a participant suggested a review, the new suggestion was made and returned via email to all participants for another round of verification until there were no more additional information. ET synthesised all the feedbacks and identified areas of agreement and consensus and presented the practice points for lymphoedema prevention, assessment, diagnosis and management.

Analysis

Analysis of Stage 1 data involved simple counts of the number of participants identifying each topic as important and/or feasible. Analysis for Stages 3 and 5 used a simple qualitative approach, with themes inductively derived from participant discussion and verified with participants then modified according to feedback [32]. At the end of Stage 4, descriptive statistics of median and range were used to indicate consensus among participants for each topic based on survey results [33, 34].

Ethical considerations

Projects building consensus among experts are not required to obtain formal ethical approval according to policy at the University of Technology Sydney provided participants agree to be identified on reports. It was made clear during recruitment that participation was voluntary for ethical consideration, and that completion of Stage 1 and/or attendance at the meeting for Stages 2 to 5 would be taken as evidence for consent. Participation included an understanding that names would be published, in accordance with common practice for consensus studies [35]. However, each participant’s responses to the survey remained anonymous. They also reserved the right to discontinue participation at any time. These terms were repeated at commencement of the meeting.

The NGT consensus was conducted between December 2021 and May 2022.

Out of the sixteen participants invited, ten completed Stage 1 (idea generation), and six attended the meeting to complete Stages 2 (round-robin) and 3 (clarification) and reach a consensus on contents for inclusion in the practice points. Participants were representatives from the disciplines of physiotherapy (n = 4), nursing (n = 1), and medicine (n = 1). All participants had more than ten years of experience of providing lymphoedema care in LMIC. All experts also had advanced education (masters or doctorate), and were affiliated to either a higher academic, research and/or health institution. The experts had expertise in providing care in the following LMIC; Bangladesh, Brazil, Cooks Islands, Egypt, Ethiopia, Ghana, Haiti, India, Ivory Coast, Papua New Guinea, and the Solomon Islands.

Consensus

Consensus was reached on twenty-five of the thirty-three items included in stages 2–5 of the NGT. The highest level of consensus was reached for lymphoedema prevention, diagnosis and non-surgical management (Refer to Tables 1 and 2 for outcome of Stage 1 of the NGT consensus), while no consensus was achieved for the surgical management of lymphoedema in LMIC. There were very low levels of support for promoting costly preventative, diagnostic or surgical interventions that required specialist equipment or capabilities. Diagnostic techniques such as indocyanine green, bioimpedance spectroscopy and lymphoscintigraphy along with the surgical procedures recommended in HIC, such as liposuction, lymphovenous anastomosis and vascularised lymph node transfer were all excluded from the lymphoedema practice points for LMIC.

Table 1 Outcome of Stage 1 of the NGT consensus on lymphoedema prevention and diagnosis
Table 2 Outcome of Stage 1 of the NGT consensus on surgical and non-surgical management

Results

Across prevention, diagnosis, assessment and management, eighteen practice points were recommended, each with accompanying key areas for the simple, practical guidance, as summarised below and detailed in Table 3. A list of societies and organisations guidelines used in the development of the practice points have been provided in Supplementary Table 1 with their web pages.

Table 3 Practice points: lymphoedema prevention, diagnosis, non-surgical and surgical management in LMIC

Of the eighteen practice points developed, five were generated under lymphoedema prevention, six under assessment, two under lymphoedema diagnosis and four under management.

Discussion

This consensus process has generated eighteen affordable and feasible practice points to support better lymphoedema care in LMIC. These practice points detail the actions LMIC health care professionals can readily implement to prevent lymphoedema, ensure it is diagnosed early, and manage the condition to prevent or reduce disability and unnecessary suffering and optimise the person’s quality of life. The NGT provided a quick and efficient method of group decision-making and ensured consensus was reached on important topics for practice point generation.

Practice points for prevention require a whole of sector approach to increase community awareness and education regarding lymphoedema, and the importance of meticulous skin care. Drawing on the Ottawa Charter, the three main health promotion strategies required to prevent lymphoedema in LMIC are: 1) advocacy to create the essential conditions to prevent lymphoedema; 2) enabling all people to achieve their full health potential; and 3) mediating between the different interests in society in the pursuit of health [45, 46]. Positive public health policies are needed to increase community awareness of lymphoedema including strengthening community action against lymphoedema [46]. Combatting lymphoedema related stigma requires the creation of an environment free from all forms of prejudice [46].

People at risk of lymphoedema, need to be provided with the skills and resources required to implement simple prevention interventions like meticulous skin care, including hand-hygiene and wearing shoes. A recent meta-analysis of lymphoedema interventional studies found that education focused on hygiene-based techniques in lymphatic filariasis-endemic areas prevented the transmission of lymphatic filariasis through proper hand washing [47], which is equally relevant to people with cancer related and other forms of lymphoedema. For the above actions lymphoedema prevention strategies to be effective, the health systems and services of LMIC require a re-orientation – an effort which should be welcomed by all levels of care (individual, community and health service). Similar to the findings of a previous research on lymphoedema care in LMIC, this NGT consensus identified that increasing community and healthcare workers awareness on lymphoedema was important first step to improving lymphoedema care outcomes in LMIC [26].

Complex decongestive therapy (CDT) is the mainstay of lymphoedema management and is critical to improving function for people living with lymphoedema, regardless of the setting. This involves manual mobilising and drainage of fluid, with meticulous skin care, which ensures a well-moisturised, healthy, clean and intact skin [48].

Practice points for lymphoedema diagnostic techniques generated through our NGT involve comparing circumferential or limb volume measurement of affected and unaffected limbs in unilateral limb lymphoedema or undertaking a baseline measurement of the affected body part. While other diagnostic techniques such as lymphoscintigraphy and Indocyanine green (ICG) florescent lymphography are effective, their prohibitive costs and limited availability makes them unsuitable for use in most LMIC [49]. It is important to promote the less expensive and more straightforward lymphoedema diagnostic methods, such as the use of the volumetric measurement, circumferential measurement as well as palpation in identifying lymphoedema suitable for use in LMIC.

Accurate diagnosis of lymphoedema was one of the major findings of our NGT consensus. Similar to the recommendation of the WHO Wound and Lymphoedema Management [13], accurate diagnosis of lymphoedema requires a detailed history, physical examination and correct measurement of limb volumes. Healthcare workers in LMIC should be taught appropriate ways of confirming if 10% of the affected limb is affected by lymphoedema (positive diagnosis) [50] so that they are able to accurately measure and interprete lymphoedema volume measurements.

Practice points generated for lymphoedema assessment include detailed subjective (history taking) and objective assessments. According to Svensson et al. [51], lymphoedema assessment should involve performing a detailed report of presenting signs and symptoms, which were consistent with our study findings that the assessment should include performing Stemmer’s test and physical examination. Despite the bioimpedance spectroscopy is widely known for measuring total fluid volume, our findings indicate that it is expensive, and not readily available for lymphoedema assessment in LMIC.

Another important finding of this study is staging of the lymphoedema. Participants indicated that for proper treatment outcomes, lymphoedema should be classified according to the stages as presented by the International Society of Lymphology [8]. Lymphoedema staging is vital for diagnosing and useful in implementing treatment interventions. A comparative study of the similarities and differences of lymphoedema between HIC and LMIC observed that healthcare workers in both countries are unaware of the disease classification system [14]. It is recommended that healthcare workers will put in efforts to understand the staging system and to implement it in the assessment and diagnosing of lymphoedema in LMIC to improve care for people living with lymphoedema.

In endemic areas of lymphatic filariasis, participants recommended that an ICT be performed. The ICT is a simple and fast method used in detecting Wuchereria bancrofti infections responsible for lymphoedema caused by lymphatic filariasis [52]. It is advised that, healthcare workers should request for ICT in cases of podoconiosis to rule out any infection of lymphatic filariasis and to aid early identification and treatment. A review of studies on non-filarial lymphoedema or podoconiosis in Africa indicated that a combination of both laboratory test and geochemical investigations are important in understanding the pathogenesis of the condition, and subsequently developing mechanisms to eradicate lymphoedema [53].

Our NGT confirmed that lymphoedema management in LMIC requires a set of coordinated effort from the multidisciplinary team of healthcare workers. Main management techniques identified in this NGT include meticulous skin care, exercise, modified lymphatic massage, and compression therapy (wraps) based on the stage of the condition. These were not different from CDT, the key management strategy for lymphoedema [31]. The main difference in LMIC is that specialist skills may be limited, and some resources may not be available for its implementation. Based on this factor, experts of our NGT suggest the use of improvised materials such as the wraps and simple treatment modalities. Additionally, this NGT consensus indicated that the management of lymphoedema should involve proper foot and skin hygiene, and wearing of appropriate foot wears in podoconiosis endemic areas. Where appropriate, lymphoedema treatment should include pelvic floor muscle exercises for people living with genital lymphoedema.

Despite the importance of surgical procedures such as lymphaticovenular anastomosis or vascularised lymph node transfer which increase limb volumes [54], these procedures require well-trained surgeons and experienced healthcare workers which are inaccessible in LMIC due to a lack of suitable facilities or cost. It is hoped that, with the advance of technology and health systems globally, LMIC will be able to secure appropriate facilities and skills to help optimise conditions for surgery. A considerable strength of these lymphoedema care practice points are the use of an international multi-disciplinary consensus process and the development of guidance that is cost-effective and feasible for all health professionals in LMIC to apply.

Limitations

Our inability to identify and include a larger number of healthcare workers providing lymphoedema care in LMIC is a limitation. However, the participants who contributed were lymphoedema experts with diverse experience across most LMIC regions.

Another limitation was not specifying specific management for various etiologies including primary, genetic or secondary lymphoedema. Instead, we provided practice points suitable for treating all kinds of lymphoedema no matter the stage of the condition. Further research should consider providing targeted treatments for genetic and non-genetic causes of lymphoedema. Finally, there is likely to have been a sampling bias and we were not able to ascertain reasons for non-response to invitations to take part in the NGT.

Implications for future research

Ideally, the practice points developed through the consensus process reported in this paper should be evaluated in research, with the gold standard being randomised controlled trials.

Implementation of these practice points will also need a concerted effort that should be underpinned by research aimed at evaluating their impacts and informing similar efforts for other guidance in the future. According to the Guidelines International Network, new guidelines should be accompanied by campaigns aimed at raising awareness, taking into account cultural and social contexts of the LMIC in which they will be implemented. Practice points should also be made readily accessible to all healthcare workers through open access journals and websites of non-governmental agencies that focus on LMIC healthcare delivery.

Lymphoedema education for healthcare workers could not be underestimated in the prevention of lymphoedema in LMIC. However, most healthcare workers lack appropriate knowledge and professional information required for lymphoedema management of people living with lymphoedema. It is appropriate that, in-service training and structured workshops with focus on increasing healthcare workers knowledge on lymphoedema be instituted to support care in LMIC.

Conclusion

Healthcare workers require increased knowledge and awareness to improve lymphoedema care in LMIC. Eighteen practice points have been developed to optimise lymphoedema care in LMIC. Key lymphoedema care strategies identified in this NGT consensus include meticulous skin care, exercise, modified lymphatic massage, and use of compression bandages or wraps. These practice points require dissemination to enhance lymphoedema care and improve clinical practice on management in LMIC.

Availability of data and materials

The datasets analysed in the current study are available from the corresponding author on reasonable request.

Abbreviations

ACI:

Agency for Clinical Innovation

APTA:

American Physical Therapy Association

BPG:

Best Practice Guideline

CDT:

Complex Decongestive Therapy

CREST:

Clinical Resource Efficiency Support Team

DLG:

Dutch Lymphoedema Guideline

HIC:

High-Income Countries

ICG:

Indocyanine Green

ICT:

Immunochromatographic Card Test

ILF:

International Lymphoedema Framework

ISL:

International Society for Lymphology

IUA:

International Union of Angiology

IUP:

International Union of Phlebology

JLSG:

The Japan Lymphoedema Study Group

LMIC:

Low- and Middle-Income Countries

NGT:

Nominal Group Technique

ONS:

The Oncology Nursing Society

QH:

Queensland Health

WHO:

World Health Organisation

References

  1. Adamczyk LA, Gordon K, Kholová I, Meijer-Jorna LB, Telinius N, Gallagher PJ, et al. Lymph vessels: the forgotten second circulation in health and disease. Virchows Archiv. 2016;469(1):3–17.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Maree JE, Beckmann D. “Just live with it”: Having to live with breast cancer related lymphoedema. Health SA Gesondheid. 2016;21(1):77–85.

    Article  Google Scholar 

  3. Son A, O’Donnell TF Jr, Izhakoff J, Gaebler JA, Niecko T, Iafrati MA. Lymphoedema-associated comorbidities and treatment gap. J Vasc Surg Venous Lymphat Disord. 2019;7(5):724–30.

    Article  PubMed  Google Scholar 

  4. Földi M, Földi E, Strößenreuther C, Kubik S. Földi's textbook of lymphology: for physicians and lymphedema therapists: Elsevier Health Sciences; 2012.

  5. Cromwell KD, Chiang Y-J, Armer J, Heppner PP, Mungovan K, Ross MI, et al. Is surviving enough? Coping and impact on activities of daily living among melanoma patients with lymphoedema. Eur J Cancer Care. 2015;24(5):724–33.

    Article  CAS  Google Scholar 

  6. Meiklejohn JA, Heesch KC, Janda M, Hayes SC. How people construct their experience of living with secondary lymphoedema in the context of their everyday lives in Australia. Support Care Cancer. 2013;21(2):459–66.

    Article  PubMed  Google Scholar 

  7. Schulze H, Nacke M, Gutenbrunner C, Hadamitzky C. Worldwide assessment of healthcare personnel dealing with lymphoedema. Heal Econ Rev. 2018;8(1):10.

    Article  Google Scholar 

  8. International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2016 consensus document of the international society of lymphology. Lymphology. 2016;49(4):170–84.

    Google Scholar 

  9. Deshpande A, Miller-Petrie MK, Lindstedt PA, Baumann MM, Johnson KB, Blacker BF, et al. The global distribution of lymphatic filariasis, 2000–18: a geospatial analysis. Lancet Glob Health. 2020;8(9):e1186–94.

    Article  Google Scholar 

  10. World Health Organisation. Lymphatic filariasis 2021 [cited 2021 19 July]. Available from: https://www.who.int/news-room/fact-sheets/detail/lymphatic-filariasis. Accessed 19 July 2021.

  11. WHO. Lymphatic filariasis: reporting continued progress towards elimination as a public health problem Geneva2020 [Available from: https://www.who.int/news/item/29-10-2020-lymphatic-filariasis-reporting-continued-progress-towards-elimination-as-a-public-health-problem. Accessed 22 Nov 2021.

  12. O'Donnell Jr TF, Allison GM, Iafrati MD. A systematic review of guidelines for lymphedema and the need for contemporary intersocietal guidelines for the management of lymphedema. J Vasc Surg Venous Lymphat Disord. 2020.

  13. World Health Organisation. Wound and lymphoedema management. Geneva2010. Available from: https://www.who.int/lymphatic_filariasis/resources/9789241599139/en/. Accessed 9 June 2020.

  14. Stout NL, Brantus P, Moffatt C. Lymphoedema management: an international intersect between developed and developing countries. Similarities, differences and challenges. Global Public Health. 2012;7(2):107–23.

  15. Tesfaye A, Semrau M, Ali O, Kinfe M, Tamiru M, Fekadu A, et al. Development of an integrated, holistic care package for people with lymphoedema for use at the level of the Primary Health Care Unit in Ethiopia. PLoS Negl Trop Dis. 2021;15(4): e0009332.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Cancer Australia. Recommendations and practice points 2022 [Available from: https://www.canceraustralia.gov.au/resources/clinical-practice-guidelines/first-line-chemotherapy-treatment-women-epithelial-ovarian-cancer/recommendations-and-practice-points. Accessed 5 June 2020.

  17. Harvey N, Holmes CA. Nominal group technique: an effective method for obtaining group consensus. Int J Nurs Pract. 2012;18(2):188–94.

    Article  PubMed  Google Scholar 

  18. Rankin NM, McGregor D, Butow PN, White K, Phillips JL, Young JM, et al. Adapting the nominal group technique for priority setting of evidence-practice gaps in implementation science. BMC Med Res Methodol. 2016;16(1):1–9.

    Article  Google Scholar 

  19. MacPhail A. Nominal group technique: a useful method for working with young people. Br Edu Res J. 2001;27(2):161–70.

    Article  Google Scholar 

  20. Irving MJ, Jan S, Tong A, Wong G, Craig JC, Chadban S, et al. What factors influence people’s decisions to register for organ donation? The results of a nominal group study. Transpl Int. 2014;27(6):617–24.

    Article  PubMed  Google Scholar 

  21. Redman S, Carrick S, Cockburn J, Hirst S. Consulting about priorities for the NHMRC National Breast Cancer Centre: how good is the nominal group technique. Aust N Z J Public Health. 1997;21(3):250–6.

    Article  CAS  PubMed  Google Scholar 

  22. The World Bank Group. World Bank Country and Lending Groups 2019 [Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups. Accessed 17 June 2019.

  23. Marcus B, Weigelt O, Hergert J, Gurt J, Gelléri P. The use of snowball sampling for multi source organizational research: Some cause for concern. Pers Psychol. 2017;70(3):635–73.

    Article  Google Scholar 

  24. Sharma G. Pros and cons of different sampling techniques. Int J Appl Res. 2017;3(7):749–52.

    Google Scholar 

  25. Torgbenu E, Luckett T, Buhagiar MA, Chang S, Phillips JL. Prevalence and incidence of cancer related lymphedema in low and middle-income countries: a systematic review and meta-analysis. BMC Cancer. 2020;20(1):604.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Torgbenu E, Luckett T, Buhagiar M, Requena CM, Phillips JL. Improving care for cancer-related and other forms of lymphoedema in low-and middle-income countries: a qualitative study. BMC Health Serv Res. 2022;22(1):1–20.

    Article  Google Scholar 

  27. Meho LI. E-mail interviewing in qualitative research: A methodological discussion. J Am Soc Inform Sci Technol. 2006;57(10):1284–95.

    Article  Google Scholar 

  28. McMillan SS, King M, Tully MP. How to use the nominal group and Delphi techniques. Int J Clin Pharm. 2016;38(3):655–62.

    PubMed  PubMed Central  Google Scholar 

  29. Morgan P, Moffatt C. An update on the Lymphoedema Framework Project. Br J Community Nurs. 2006;11(10):S20–1.

    Article  PubMed  Google Scholar 

  30. Armer JM, Ostby PL, Ginex PK, Beck M, Deng J, Fu MR, et al. ONS guidelines™ for Cancer Treatment-Related Lymphedema. Oncol Nurs Forum. 2020;47(5):518–38.

    Article  PubMed  Google Scholar 

  31. Gebruers N, Verbelen H, De Vrieze T, Vos L, Devoogdt N, Fias L, et al. Current and future perspectives on the evaluation, prevention and conservative management of breast cancer related lymphoedema: A best practice guideline. Eur J Obstet Gynecol Reprod Biol. 2017;216:245–53.

    Article  PubMed  Google Scholar 

  32. McMillan SS, Kelly F, Sav A, Kendall E, King MA, Whitty JA, et al. Using the nominal group technique: how to analyse across multiple groups. Health Serv Outcomes Res Method. 2014;14:92–108.

    Article  Google Scholar 

  33. Doke ER, Swanson NE. Decision variables for selecting prototyping in information systems development: a Delphi study of MIS managers. Inform Manag. 1995;29(4):173–82.

    Article  Google Scholar 

  34. Holey EA, Feeley JL, Dixon J, Whittaker VJ. An exploration of the use of simple statistics to measure consensus and stability in Delphi studies. BMC Med Res Methodol. 2007;7(1):52.

    Article  PubMed  PubMed Central  Google Scholar 

  35. The AGREE II Instrument [Electronic version]. [Internet]. 2017 [cited 10 October 2020]. Available from: http://www.agreetrust.org. Accessed 10 Oct 2020.

  36. Agency for Clinical Innovation Chronic Care Network. Lymphoedema: A guide for clinical services 2018 [Available from: https://www.aci.health.nsw.gov.au/__data/assets/pdf_file/0008/477998/lymphoedema-guide.pdf. Accessed 30 Jan 2020.

  37. Lee BB, Andrade M, Antignani PL, Boccardo F, Bunke N, Campisi C, et al. Diagnosis and treatment of primary lymphedema. Consensus document of the International Union of Phlebology (IUP)-2013. Int Angiol. 2013;32(6):541–74.

  38. Perdomo M, Ryans K, Levenhagen K, Davies CC, Gilchrist L. Clinical implementation of the clinical practice guidelines for diagnosing upper-quadrant lymphedema secondary to cancer. Rehab Oncol. 2018;36(3):E11–8.

    Google Scholar 

  39. Lee BB, Antignani PL, Baroncelli TA, Boccardo FM, Brorson H, Campisi C, et al. IUA-ISVI consensus for diagnosis guideline of chronic lymphedema of the limbs. Int Angiol. 2015;34(4):311–32.

    Article  CAS  PubMed  Google Scholar 

  40. Clinical Resource Efficiency Support Team. Guidelines for the diagnosis, assessment and management of lymphoedema: Clinical Resource Efficiency Support Team; 2008.

  41. Manji K, Hanefeld J, Vearey J, Walls H, de Gruchy T. Using WhatsApp messenger for health systems research: a scoping review of available literature. Health Policy Plan. 2021;36(5):774–89.

    Article  PubMed Central  Google Scholar 

  42. Queensland Health. Queensland Health lymphoedema clinical practice guideline 2014 [Available from: https://www.health.qld.gov.au/__data/assets/pdf_file/0027/146646/guideline-lymph.pdf.

  43. Davies C, Levenhagen K, Ryans K, Perdomo M, Gilchrist L. Interventions for breast cancer-related lymphedema: clinical practice guideline from the academy of oncologic physical therapy of APTA. Phys Ther. 2020;100(7):1163–79.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Kitamura K, Iwase S, Kuroda Y, Yamaguchi T, Yamamoto D, Odagiri H, et al. A practice guideline for the management of lymphoedema. J Lymphoedema. 2011;6(2):60–71.

    Google Scholar 

  45. Thompson SR, Watson MC, Tilford S. The Ottawa Charter 30 years on: still an important standard for health promotion. Int J Health Promot Educ. 2018;56(2):73–84.

    Article  Google Scholar 

  46. World Health Organization. Ottawa charter for health promotion. Health Promot. 1986;1:iii–v.

    Google Scholar 

  47. Stocks ME, Freeman MC, Addiss DG. The effect of hygiene-based lymphedema management in lymphatic filariasis-endemic areas: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2015;9(10): e0004171.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Nowicki J, Siviour A. Best practice skin care management in lymphoedema. Wound Pract Res J Austral Wound Manag Assoc. 2013;21(2):61–5.

    Google Scholar 

  49. Mahieu R, Krijger GC, Ververs FT, de Roos R, de Bree R, de Keizer B. [68 Ga] Ga-tilmanocept PET/CT lymphoscintigraphy: a novel technique for sentinel lymph node imaging. Eur J Nucl Med Mol Imaging. 2021;48:963–5. 

  50. Cheville AL, Nyman JA, Pruthi S, Basford JR. Cost considerations regarding the prospective surveillance model for breast cancer survivors. Cancer. 2012;118(S8):2325–30.

    Article  PubMed  Google Scholar 

  51. Svensson BJ, Dylke ES, Ward LC, Black DA, Kilbreath SL. Screening for breast cancer–related lymphoedema: self-assessment of symptoms and signs. Support Care Cancer. 2020;28(7):3073–80.

    Article  CAS  PubMed  Google Scholar 

  52. Weil GJ, Lammie PJ, Weiss N. The ICT filariasis test: a rapid-format antigen test for diagnosis of bancroftian filariasis. Parasitol Today. 1997;13(10):401–4.

    Article  CAS  PubMed  Google Scholar 

  53. Wanji S, Deribe K, Minich J, Debrah AY, Kalinga A, Kroidl I, et al. Podoconiosis-From known to unknown: Obstacles to tackle. Acta Trop. 2021;219: 105918.

    Article  CAS  PubMed  Google Scholar 

  54. Phillips GSA, Gore S, Ramsden A, Furniss D. Lymphaticovenular anastomosis in the treatment of secondary lymphoedema of the legs after cancer treatment. J Plast Reconstr Aesthet Surg. 2019;72(7):1184–92.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors acknowledge the staff and students of IMPACCT, University of Technology Sydney for their immense support during Journal Club Meetings. The authors would also like to acknowledge all participants for their contributions to the development of the guidance.

Funding

This project was funded by the Translational Cancer Research Network (TCRN) PhD Scholarship Top- up award, supported by the Cancer Network NSW.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to manuscript writing, editing and final approval, including table design. E.T, T.L, M.B, and J.L.P conceived the study. E.T, T.L, M.B, and J.L.P facilitated recruitment. E.T, and T.L led the data collection. Data analysis was performed by E.T with consensus discussions with T.L, M.B, and J.L.P. All authors reviewed the draft manuscript and provided approval to the final manuscript.

Corresponding author

Correspondence to Eric Torgbenu.

Ethics declarations

Ethics approval and consent to participate

Studies involving consensus process are not required to obtain ethics according to the National Statement on Ethical Conduct in Human Research developed jointly by the National Health and Medical Research Council, the Australian Research Council and Universities Australia. Consequently, projects building consensus among experts are not required to obtain formal ethical approval according to policy at the University of Technology Sydney provided participants agree to be identified on reports. It was made clear during recruitment that participation was voluntary, and that completion of Stage 1 and/or attendance at the meeting for Stages 2 to 5 would be taken as evidence for consent. Participation included an understanding that names would be published, in accordance with common practice for consensus studies [35]. However, each participant’s responses to the survey remained anonymous. Participants also reserved the right to discontinue participation at any time. These terms were repeated at commencement of the meeting. All methods were carried out in accordance with relevant guidelines and regulations, for example the Declaration of Helsinki.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Torgbenu, E., Luckett, T., Buhagiar, M. et al. Practice points for lymphoedema care in low- and middle- income countries developed by nominal group technique. BMC Health Serv Res 23, 740 (2023). https://doi.org/10.1186/s12913-023-09786-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12913-023-09786-w

Keywords